Moleculin Biotech, Inc. MBRX · Stock Open Moleculin Biotech, Inc. in new tab
Moleculin Biotech, Inc. Analysis (MBRX)
Is Moleculin Biotech, Inc. a good investment? Moleculin Biotech, Inc. (MBRX) is currently trading at 0.5202 USD. Market analysts have a consensus price target of 12.00 USD. This suggests a potential upside from current levels.
In terms of valuation, the stock trades at a P/E ratio of 0.05. This relatively low multiple may signal that Moleculin Biotech, Inc. is undervalued compared to historical market norms.
Earnings Schedule: Moleculin Biotech, Inc. is expected to release its next earnings report on Nov. 12, 2026. The market consensus estimate for Forward EPS is -110.50.
Investor FAQ
Does Moleculin Biotech, Inc. pay a dividend?
No, it does not currently pay a dividend.
What asset class is Moleculin Biotech, Inc.?
Moleculin Biotech, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.
When is the next earnings date?
The next earnings date is projected to be Nov. 12, 2026. The company currently has a trailing EPS of 14.59.
Company Profile
Moleculin Biotech, Inc., a late-stage pharmaceutical development company, engages in the development of therapeutic candidates for the treatment of tumors and viruses. Its lead drug candidate is Annamycin, an anthracycline, which is in clinical stage for the treatment of relapsed or refractory acute myeloid leukemia and soft tissue sarcoma lung metastases. The company is also developing WP1066 portfolio, including WP1066, WP1193, and WP1220, which are immune/transcription modulators designed to inhibit phosphorylated signal transducer and activator of transcription for brain tumors and pancreatic and other cancers. In addition, it is developing WP1122 portfolio, such as WP1122, WP1096, and WP1097 designed to exploit the uses of inhibitors of glycolysis comprising 2-deoxy-D-glucose that cut off the energy supply of tumors. The company was incorporated in 2015 and is headquartered in Houston, Texas.
| Split Date | Split Ratio to 1 |
|---|---|
| Feb. 1, 2021 | 0.17 |
| March 22, 2024 | 0.07 |
| Dec. 1, 2025 | 1:25 |
Community Discussion